PE
PE Firm Index
Public-Source Directory
Portfolio Company · Operating Co.
O

OncoResponse

Not on record
backed byBering Capital and Canaan Partners
Current
OncoResponse
a portfolio company of
Bering Capital
Status on record: Current
PE Firm Index
OncoResponse
a portfolio company of
Canaan Partners
Status on record: Current
PE Firm Index

Who owns OncoResponse?

OncoResponse is listed on the portfolio pages of Bering Capital (portfolio page) and Canaan Partners (portfolio page). Bering Capital and Canaan Partners list it as current.

Company Snapshot

OncoResponse's owner on record, Bering Capital, is a firm. Bering Capital lists 14 companies in the index. Also backed by Canaan Partners.

SectorNot on record
Backed byBering Capital and Canaan Partners
Ownership statusCurrent
WebsiteNot on record

About the owner

Questions about OncoResponse

Who owns OncoResponse?

OncoResponse is listed on the portfolio pages of Bering Capital (portfolio page) and Canaan Partners (portfolio page). Bering Capital and Canaan Partners list it as current.

Sources

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with OncoResponse and does not provide investment advice.

Other portfolio companies of Bering Capital

6 of 13 shown

AP
Atea Pharmaceuticals
C
Calcimedica
C
Cellworks
CB
Coherus BioSciences
CO
Coherus Oncology
DV
Dragon Vascular

See the full Bering Capital portfolio.

Other portfolio companies of Canaan Partners

6 of 348 shown

A
Abyrx
A
Aceiss
Acesion Pharma ApS logo
Acesion Pharma ApS
AB
Actio Biosciences, Inc.
AN
ACTIVE Network
ActualyzeAI, Inc. logo
ActualyzeAI, Inc.

See the full Canaan Partners portfolio.